Biorepository of Lung Disease-Specific Human Induced Pluripotent Stem Cells
Closed Pre-Solicitation Posted
- Solicitation number
- 75N92019R0052
- Agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Bethesda, Maryland 20892, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Heart, Lung, and Blood Institute intends to award a single source contract to Boston University to establish and maintain a Biorepository of Lung Disease-Specific Human Induced Pluripotent Stem Cells. The contractor must recruit patients, generate induced pluripotent stem cell lines from patient samples, conduct differentiation of cell types and RNA sequencing, provide training and distribute biorepository materials. Capability statements from interested parties are due by January 9, 2020. The anticipated period of performance is a base year starting in May 2020 with four consecutive one-year options.
There is no set-aside designation for this procurement. The primary NAICS code is 541711 and PSC code is R425. The incumbent contractor is Boston University. The value of the award is estimated at $2.5M per year for a total of $12.5M over the five year period of performance. The contractor will be expected to generate at least 100 new induced pluripotent stem cell lines from patient samples during the contract period.
Notice text
THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).
This acquisition is conducted under the authority of 41 U.S.C. 253(c) under provisions of the statutory authority of FAR subpart 6.302-1.
The National Heart, Lung, and Blood Institute (NHLBI) intends to negotiate and award a contract without providing for full and open competition (including brand-name) to Boston University for the Biorepository of Lung Disease-Specific Human Induced Pluripotent Stem Cells. It is anticipated that one award will be made around May 2020 for a period of five (5) years.
THIS IS A SYNOPSIS. THIS IS NOT A SOLICITATION. PLEASE SEE ATTACHMENT
Files
| File | Type | Posted |
|---|---|---|
| presol_ips-biorepository_noi.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Pre-Solicitation | |
| Biorepository of Lung Disease-Specific Human Induced Pluripotent Stem Cells | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| iPSC Culture and Differentiation | Office of Logisitics and Acquisition Operations | No set-aside | |
| NOI - DNA Sequencing of Bone Marrow Failure Syndro | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity